Hsian-Rong Tseng
Affiliations: | Biomedical Engineering 0289 | University of California, Los Angeles, Los Angeles, CA |
Area:
Biomedical Engineering, NanotechnologyGoogle:
"Hsian-Rong Tseng"Parents
Sign in to add mentorTien-Yau Luh | grad student | 1994-1998 | National Taiwan University (Chemistry Tree) |
Children
Sign in to add traineeTak F. Yu | grad student | 2009 | UCLA |
Kuan-Ju Chen | grad student | 2012 | UCLA |
Mitch André Garcia | post-doc | 2010-2013 | UCLA (Chemistry Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Court CM, Hou S, Liu L, et al. (2020) Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells. Npj Precision Oncology. 4: 16 |
Wang J, Sun N, Lee YT, et al. (2020) A circulating tumor cell-based digital assay for the detection of EGFR T790M mutation in advanced non-small cell lung cancer. Journal of Materials Chemistry. B |
Ahn JC, Teng PC, Chen PJ, et al. (2020) Detection of circulating tumor cells and their implications as a novel biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma. Hepatology (Baltimore, Md.) |
Teng P, Jan YJ, Chen J, et al. (2020) Prostate cancer CTC-RNA Assay: A new method for contemporary genomics and precision medicine via liquid biopsy. Journal of Clinical Oncology. 38: 170-170 |
Wang JJ, Teng P, Jan YJ, et al. (2020) Association of very small nuclear circulating tumor cell (vsnCTC) with clinical outcomes in metastatic castration-resistant prostate cancer. Journal of Clinical Oncology. 38: 168-168 |
Wang JJ, Teng P, Jan YJ, et al. (2020) Circulating tumor cells with small nuclear size: A novel biomarker for survival and clinical outcomes in advanced prostate cancer. Journal of Clinical Oncology. 38 |
Teng P, Jan YJ, Kim M, et al. (2020) Development of a circulating tumor cell-based RNA classifier for patients with castration-resistant prostate cancer: CTC-PCS/PAM50. Journal of Clinical Oncology. 38 |
Wang JJ, Teng P, Jan YJ, et al. (2020) Abstract 4331: Nuclear size of circulating tumor cells is associated with prognosis in metastatic, castration-resistant prostate cancer Endocrinology |
Dong J, Chen J, Smalley M, et al. (2020) Circulating Rare Cells: Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications (Adv. Mater. 1/2020) Advanced Materials. 32: 2070008 |
Dong J, Chen JF, Smalley M, et al. (2019) Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications. Advanced Materials (Deerfield Beach, Fla.). e1903663 |